NIH-funded research R01 grant

Understanding how certain proteins help parasites invade host cells

Official title: Control of parasite invasion by a microneme protein complex conserved in Apicomplexans

Funded at Whitehead Institute for Biomedical Res · NIH-10737623 · Data updated 2026-11-12

This study is looking at how certain parasites, like those that cause malaria and toxoplasmosis, get into our cells, and it’s trying to find new ways to help treat these infections by understanding the proteins that help them invade.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWhitehead Institute for Biomedical Res
NIH-funded
Lab location1 site (Cambridge, United States)
Project startDecember 1, 2019
Project endNovember 30, 2025
Funding year2024
Award (this year)$487,500
NIH project number5R01AI144369-05
Project IDNIH-10737623 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals affected by malaria or cryptosporidiosis.

Less likely to help

Patients with non-parasitic infections or conditions unrelated to Apicomplexan parasites may not receive any benefit from this research.

What this research studies

This research investigates how Apicomplexan parasites, which cause diseases like malaria and toxoplasmosis, invade human and animal cells. It focuses on a specific protein complex that plays a crucial role in the invasion process by facilitating the release of other proteins necessary for the parasites to enter host cells. By studying these molecular interactions, the research aims to uncover new insights into the mechanisms of infection and potentially identify targets for new treatments. Patients may benefit from this research as it could lead to improved therapies for infections caused by these parasites.

Why it matters

Potential benefit: If successful, this research could lead to the development of new treatments for serious parasitic infections.

How similar studies have gone: Other research has shown success in targeting similar mechanisms in parasitic infections, indicating potential for breakthroughs in treatment.

Where this research is happening

  • Whitehead Institute for Biomedical Res
    Cambridge, United States
    Active

Researchers

  • Principal investigator: Lourido, Sebastian — Whitehead Institute for Biomedical Res
  • Study coordinator: Lourido, Sebastian

Related research

Other NIH-funded projects on the same topics.

  • Illuminating the dark proteome to fight cancer

    A research program aims to map and understand mysterious dark proteome proteins in cancer and to develop pre-clinical therapies that target them.

    NIH research Whitehead Institute for Biomedical Res · Cambridge, United States · NIH-11516315

  • Center for Genome Editing and Recording: Next-Generation Genome and Epigenome Tools for Disease

    A research center is developing ultra-precise genome and epigenome editing tools to better understand and treat human diseases, with a focus on how genetic variants influence disease and how to safely modify them.

    NIH research Whitehead Institute for Biomedical Res · Cambridge, United States · NIH-11412455

  • Understanding how polyamines work in human cells (a potential cancer focus)

    Researchers are studying how small molecules called polyamines help cancer-related cell growth and survival, with new ways to measure them inside living cells.

    NIH research Whitehead Institute for Biomedical Res · Cambridge, United States · NIH-11398143

  • Delivering therapeutic macromolecules with cell-derived bioparticles

    A researcher aims to safely and efficiently deliver big therapeutic molecules into human cells using cell-derived bioparticles to help treat diseases.

    NIH research Whitehead Institute for Biomedical Res · Cambridge, United States · NIH-11382122

  • Stem cell and regeneration rules in planarians

    Researchers study how planarians regulate stem cells to regrow body parts, hoping to reveal ideas that could someday help human tissue repair.

    NIH research Whitehead Institute for Biomedical Res · Cambridge, United States · NIH-11349754

  • Post-transcriptional gene regulation in human cells

    A grant studying how microRNAs control which genes are turned on or off in human cells, with a focus on cancer and development.

    NIH research Whitehead Institute for Biomedical Res · Cambridge, United States · NIH-11329480

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.